InvestorsHub Logo
Followers 2
Posts 105
Boards Moderated 0
Alias Born 10/18/2019

Re: biotech_researcher post# 9202

Monday, 10/21/2019 2:16:19 PM

Monday, October 21, 2019 2:16:19 PM

Post# of 17447
a quick answer to that shorter article :

1) regarding the numbers of patients that completed CR in the low dose, it was 29 https://www.ncbi.nlm.nih.gov/pubmed/30420324

2) regarding the patients who completed the trial. it was very clear in the company presentation that 16 in total didn't complete the trial. 10 of them died ( 5 while still taking VCS and 5 after they stopped taking VCS) . so the number is 16 and NOT 21 . And regarding the 11 that he mentioned 6 quit for different reasons and 5 quit before they died, but the total is 16 (including the 10 dead).and the regarding the 10 dead, everyone know by now that it had nothing to do with the drug

so this article is a clear short attack ahead of the coming results. the writer is trying to play on numbers and create a foggy environment just to raise doubts in those who did not do enough DD
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News